Literature DB >> 18156153

Chromosomal profiles of gene expression in Huntington's disease.

Alexander N Anderson1, Federico Roncaroli, Angela Hodges, Manuel Deprez, Federico E Turkheimer.   

Abstract

Recent studies suggested that Huntington's disease is due to aberrant interactions between mutant huntingtin protein, transcription factors and transcriptional co-activators resulting in widespread transcriptional dysregulation. Mutant huntingtin also interacts with histone acetyltransferases, consequently interfering with the acetylation and deacetylation states of histones. Because histone modifications and chromatin structure coordinate the expression of gene clusters, we have applied a novel mathematical approach, Chromowave, to analyse microarray datasets of brain tissue and whole blood to understand how genomic regions are altered by the effects of mutated huntingtin on chromatin structure. Results show that, in samples of caudate and whole blood from Huntington's disease patients, transcription is indeed deregulated in large genomic regions in coordinated fashion, that transcription in these regions is associated with disease progression and that altered chromosomal clusters in the two tissues are remarkably similar. These findings support the notion of a common genome-wide mechanism of disruption of RNA transcription in the brain and periphery of Huntington's disease patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18156153     DOI: 10.1093/brain/awm312

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  22 in total

Review 1.  Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Authors:  Mark F Mehler
Journal:  Prog Neurobiol       Date:  2008-10-17       Impact factor: 11.685

2.  Chromatin from peripheral blood mononuclear cells as biomarkers for epigenetic abnormalities in schizophrenia.

Authors:  David P Gavin; Rajiv P Sharma
Journal:  Cardiovasc Psychiatry Neurol       Date:  2009-07-22

3.  Mutant huntingtin impairs immune cell migration in Huntington disease.

Authors:  Wanda Kwan; Ulrike Träger; Dimitrios Davalos; Austin Chou; Jill Bouchard; Ralph Andre; Aaron Miller; Andreas Weiss; Flaviano Giorgini; Christine Cheah; Thomas Möller; Nephi Stella; Katerina Akassoglou; Sarah J Tabrizi; Paul J Muchowski
Journal:  J Clin Invest       Date:  2012-11-19       Impact factor: 14.808

Review 4.  Pharmacology of epigenetics in brain disorders.

Authors:  Pritika Narayan; Mike Dragunow
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

5.  Epigenetics-Based Therapeutics for Neurodegenerative Disorders.

Authors:  Zihui Xu; He Li; Peng Jin
Journal:  Curr Transl Geriatr Exp Gerontol Rep       Date:  2012-09-18

Review 6.  The role of genetics in the establishment and maintenance of the epigenome.

Authors:  Covadonga Huidobro; Agustin F Fernandez; Mario F Fraga
Journal:  Cell Mol Life Sci       Date:  2013-03-10       Impact factor: 9.261

7.  Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner.

Authors:  Caroline L Benn; Tingting Sun; Ghazaleh Sadri-Vakili; Karen N McFarland; Derek P DiRocco; George J Yohrling; Timothy W Clark; Bérengère Bouzou; Jang-Ho J Cha
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

8.  Platelet-derived extracellular vesicles in Huntington's disease.

Authors:  Hélèna L Denis; Jérôme Lamontagne-Proulx; Isabelle St-Amour; Sarah L Mason; Andreas Weiss; Sylvain Chouinard; Roger A Barker; Eric Boilard; Francesca Cicchetti
Journal:  J Neurol       Date:  2018-09-12       Impact factor: 4.849

9.  Downregulation of genes involved in metabolism and oxidative stress in the peripheral leukocytes of Huntington's disease patients.

Authors:  Kuo-Hsuan Chang; Yi-Chun Chen; Yih-Ru Wu; Wan-Fen Lee; Chiung-Mei Chen
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

10.  Mean Expression of the X-Chromosome is Associated with Neuronal Density.

Authors:  James T Swingland; Pascal F Durrenberger; Richard Reynolds; David T Dexter; Ana Pombo; Manuel Deprez; Federico Roncaroli; Federico E Turkheimer
Journal:  Front Neurosci       Date:  2012-11-12       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.